Image

Swallowing Impairments in Adults With and Without Alzheimer's Disease

Swallowing Impairments in Adults With and Without Alzheimer's Disease

Recruiting
60 years and older
All
Phase N/A

Powered by AI

Overview

This research study is investigating whether people with Alzheimer's disease (AD) experience more changes to swallowing than their healthy age-matched peers. The prevalence of swallowing impairments in moderate-severe AD is high (85-93%), yet little is known about how swallow function evolves throughout the disease course in people with AD. The overall objective of this study is to evaluate swallowing function in adults with and without Alzheimer's disease. The investigator will also be involving the primary caregivers of individuals with Alzheimer's that are enrolled in the study to better understand the impact of swallowing impairments on the primary caregivers of those with Alzheimer's Disease.

Healthy adults and individuals with Alzheimer's disease will:

  • undergo tests of cough and swallow function
  • undergo tests of grip and tongue strength
  • complete questionnaires

Caregivers of individuals with Alzheimer's disease will also complete questionnaires.

Description

This study will involve one in-person research visit that will last approximately 1-1.5 hours and will consist of a screening, cough testing, swallow function testing, assessments of hand grip and tongue strength, and completion of questionnaires. Caregivers of those with Alzheimer's disease will also complete questionnaires.

Eligibility

Inclusion criteria for AD cohort:

  1. adult ≥60 years old
  2. diagnosis of AD by a neurologist (confirmed with imaging, spinal tap, behavioral testing)
  3. no prior history of other neurological diseases (aside from stroke which has resolved with no current symptoms)
  4. no prior history of respiratory diseases
  5. no prior history of head and neck surgery/head and neck cancer/radiation to head and neck region
  6. consuming some form of oral intake
  7. able to follow basic directions
  8. able/willing to provide consent/assent.

Exclusion Criteria for AD Cohort:

  1. individual <60 years old
  2. Diagnosis of another type of dementia
  3. History of neurological/respiratory diseases
  4. History of head and neck surgery/head and neck cancer/radiation to head and neck region
  5. not consuming any oral intake
  6. Unable to follow basic directions
  7. Unable to provide consent based on the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC), score <15 OR provide assent and a legal guardian provides consent.

Inclusion criteria for care partners of individuals with AD will be:

  1. care partner of an individual with AD
  2. willing to complete questionnaires/participate in an interview.

Exclusion Criteria for Caregivers of Individuals with AD:

  1. not the primary caregiver of an individual with AD
  2. unwilling to complete questionnaires/semi-structured interview

Inclusion criteria for community-dwelling adults will be:

  1. adult ≥60 years old
  2. no prior history of neurological diseases (aside from stroke which has resolved with no current symptoms)
  3. no prior history of respiratory diseases
  4. no prior history of head and neck surgery/head and neck cancer/radiation to head and neck region 4) no prior history of swallowing difficulties based on participant report. 5) Score ≥25th percentile based on sex/age/education/race on the Montreal Cognitive Assessment (MOCA)

Exclusion Criteria for Healthy Cohort:

  1. individual <60 years old
  2. history of neurological disease
  3. history of respiratory disease
  4. history of head and neck surgery/head and neck cancer/radiation to head and neck region
  5. history of swallowing difficulties
  6. Score <25th percentile based on sex/age/education/race on the Montreal Cognitive Assessment (MOCA)

Study details
    Alzheimer Disease
    Caregiver Burden
    Healthy Aging
    Dysphagia

NCT06678100

Vanderbilt University Medical Center

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.